華億金控(08123.HK)預期年度虧損約4200萬港元
格隆匯3月11日丨華億金控(08123.HK)發佈公吿,與2019年相應期間錄得的虧損1.34億港元相比,公司預期截至2020年12月31日止年度將錄得虧損約4200萬港元。
董事會認為,相關期間虧損乃主要由於集團於相關期間於從事新藥開發項目投資的有限合夥企業的分類為按公平值計入損益的金融資產的非上市股權投資產生的重大公平值虧損約1600萬港元;及與集團汽車銷售分部有關的貿易按金減值約1100萬港元所致。
集團管理層認為,於相關期間汽車銷售分部的收益大幅減少導致集團於相關期間產生虧損;及公平值虧損(即一筆非現金會計處理)將不會對集團的正常營運及流動現金狀況帶來任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.